The sacral chordoma margin.
暂无分享,去创建一个
P. Georg | P. Navarria | D. Campanacci | K. Mazzocco | P. Bruzzi | C. Zoccali | A. D. Dei Tos | T. Delaney | P. Casali | A. Gronchi | P. Picci | S. Stacchiotti | A. Trama | C. Valverde | R. Vergés | C. Court | M. Uhl | M. Spałek | P. Boland | L. Porcu | A. Gasbarrini | R. Jones | P. Parchi | A. Frezza | S. Scheipl | G. Grignani | B. Timmermann | R. Casadei | D. Donati | Ø. Bruland | A. D. Krol | A. Brunello | D. Weber | S. Patel | M. Gambarotti | R. Capanna | A. Kawai | M. Petrongari | T. Akiyama | E. Hug | P. Varga | N. Hindi | J. M. Asencio | P. Fossati | C. Sangalli | E. Pennacchioli | L. Di Brina | M. R. Fiore | S. Bolle | A. De Paoli | V. Quagliuolo | A. Luzzati | T. Steinmeier | S. Bandiera | R. Pollock | S. Radaelli | A. Desai | A. Paoli | A. Boglione | F. le Grange | G. Marquina | F. Navarria | G. Scotto | F. Cananzi | J. Sommer | N. Fabbri | A. Cordoba | L. Brina | T. de Pas | J. A. Martín-Benlloch | A. Krol | T. D. De Pas | J. Martín-Benlloch | P. G. Casali | T. D. Pas | A. Tos | F. L. Grange | Matthias Uhl | Toru Akiyama | R. Jones | D. Campanacci | D. M. Donati
[1] Juha Kiiski,et al. Clinical results and quality of life after reconstruction following sacrectomy for primary bone malignancy. , 2018, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[2] D. Campanacci,et al. Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome. , 2018, Surgical technology international.
[3] L. Mariani,et al. Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study , 2018, Cancer.
[4] Y. Lim,et al. Clinical outcome of proton therapy for patients with chordomas , 2018, Radiation oncology journal.
[5] J. Debus,et al. Sacral insufficiency fractures after high-dose carbon-ion based radiotherapy of sacral chordomas , 2018, Radiation Oncology.
[6] Kei Yamada,et al. Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy. , 2017, International journal of radiation oncology, biology, physics.
[7] Seiichi Matsumoto,et al. Analysis of the Infiltrative Features of Chordoma: The Relationship Between Micro-Skip Metastasis and Postoperative Outcomes , 2018, Annals of Surgical Oncology.
[8] Z. Gokaslan,et al. Comprehensive biomechanical analysis of three reconstruction techniques following total sacrectomy: an in vitro human cadaveric model. , 2017, Journal of neurosurgery. Spine.
[9] Eva Ardanaz,et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. , 2017, The Lancet. Oncology.
[10] J. Blay,et al. Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF). , 2017, European Journal of Cancer.
[11] S. Kunakornsawat,et al. What Are the Functional Outcomes After Total Sacrectomy Without Spinopelvic Reconstruction? , 2017, Clinical orthopaedics and related research.
[12] Wei Guo,et al. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma? , 2017, Clinical orthopaedics and related research.
[13] P. A. Gardner,et al. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] A. Niemierko,et al. Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy. , 2017, International journal of radiation oncology, biology, physics.
[15] Xiaohui Niu,et al. Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute , 2017, European Spine Journal.
[16] Z. Gokaslan,et al. Soft Tissue and Bone Defect Management in Total Sacrectomy for Primary Sacral Tumors: A Systematic Review With Expert Recommendations , 2016, Spine.
[17] C. Bettegowda,et al. Management of Locally Recurrent Chordoma of the Mobile Spine and Sacrum: A Systematic Review , 2016, Spine.
[18] R. Orecchia,et al. Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] N. Araki,et al. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases. , 2016, International journal of radiation oncology, biology, physics.
[20] P. Casali,et al. Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers , 2016, Spine.
[21] T. Delaney,et al. Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery , 2016, Clinical orthopaedics and related research.
[22] C. Zoccali,et al. Residual neurological function after sacral root resection during en-bloc sacrectomy: a systematic review , 2016, European Spine Journal.
[23] Christine S. M. Lau,et al. Pediatric Chordomas: A Population-Based Clinical Outcome Study Involving 86 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011) , 2016, Pediatric Neurosurgery.
[24] Kimberly-Anne Tan,et al. Prognostic Factors in the Operative Management of Sacral Chordomas. , 2015, World neurosurgery.
[25] G. Nielsen,et al. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. , 2015, Journal of neurosurgery. Spine.
[26] P. Ruggieri,et al. Prognostic factors in surgical resection of sacral chordoma , 2015, Journal of surgical oncology.
[27] T. Witham,et al. Soft-tissue reconstruction after total en bloc sacrectomy. , 2015, Journal of neurosurgery. Spine.
[28] K. Herfarth,et al. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma , 2015, Strahlentherapie und Onkologie.
[29] C. Zoccali,et al. The surgical neurovascular anatomy relating to partial and complete sacral and sacroiliac resections: a cadaveric, anatomic study , 2015, European spine journal.
[30] S. Stacchiotti,et al. Building a global consensus approach to chordoma: a position paper from the medical and patient community. , 2015, The Lancet. Oncology.
[31] M. Fehlings,et al. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival , 2015, European Spine Journal.
[32] B. Yeap,et al. Long‐term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas , 2014, Journal of surgical oncology.
[33] R. Sasaki,et al. Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma. , 2014, The British journal of radiology.
[34] M. McDonald,et al. Clinical Investigation : Central Nervous System Tumor Proton Therapy for Reirradiation of Progressive or Recurrent Chordoma , 2013 .
[35] D. Kirsch,et al. Definitive High-Dose Photon/Proton Radiotherapy for Unresected Mobile Spine and Sacral Chordomas , 2013, Spine.
[36] K. Schaller,et al. Incidence and relative survival of chordomas , 2013, Cancer.
[37] Wei Guo,et al. One-Stage Total En Bloc Sacrectomy: A Novel Technique and Report of 9 Cases , 2013, Spine.
[38] Roberto Orecchia,et al. Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy , 2012, Physics in medicine and biology.
[39] M. Durante,et al. Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy. , 2012, International journal of radiation oncology, biology, physics.
[40] S. Waikakul,et al. Wide resection of sacral chordoma via a posterior approach , 2012, International Orthopaedics.
[41] Francesca Albertini,et al. Spot-scanning-based proton therapy for extracranial chordoma. , 2011, International journal of radiation oncology, biology, physics.
[42] R. Imai,et al. Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. , 2011, International journal of radiation oncology, biology, physics.
[43] P. Ruggieri,et al. Surgical Margins and Local Control in Resection of Sacral Chordomas , 2010, Clinical orthopaedics and related research.
[44] B. Yeap,et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. , 2009, International journal of radiation oncology, biology, physics.
[45] T. Delaney,et al. Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. , 2006, International journal of radiation oncology, biology, physics.
[46] F. Sim,et al. Operative management of sacral chordoma. , 2005, The Journal of bone and joint surgery. American volume.
[47] L. Kindblom,et al. Prognostic factors in chordoma of the sacrum and mobile spine , 2000, Cancer.
[48] P. Michenet,et al. Sacrococcygeal chordomas: potential role of high LET therapy. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.